These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 6361041)

  • 1. Studies on the antigenicity of bone. II. Donor-specific anti-HLA antibodies in human recipients of freeze-dried allografts.
    Friedlaender GE; Strong DM; Sell KW
    J Bone Joint Surg Am; 1984 Jan; 66(1):107-12. PubMed ID: 6361041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigenicity of freeze-dried cortical bone allograft in human periodontal osseous defects.
    Quattlebaum JB; Mellonig JT; Hensel NF
    J Periodontol; 1988 Jun; 59(6):394-7. PubMed ID: 2455783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the antigenicity of bone. I. Freeze-dried and deep-frozen bone allografts in rabbits.
    Friedlaender GE; Strong DM; Sell KW
    J Bone Joint Surg Am; 1976 Sep; 58(6):854-8. PubMed ID: 783164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel ELISA-based crossmatch procedure to detect donor-specific anti-HLA antibodies responsible for corneal allograft rejections.
    Sel S; Schlaf G; Schurat O; Altermann WW
    J Immunol Methods; 2012 Jul; 381(1-2):23-31. PubMed ID: 22561526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue-typing in human massive allografts of frozen bone.
    Muscolo DL; Caletti E; Schajowicz F; Araujo ES; Makino A
    J Bone Joint Surg Am; 1987 Apr; 69(4):583-95. PubMed ID: 2952660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aortic valve allograft structural deterioration is associated with a subset of antibodies to human leukocyte antigens.
    Dignan R; O'Brien M; Hogan P; Thornton A; Fowler K; Byrne D; Stephens F; Harrocks S
    J Heart Valve Dis; 2003 May; 12(3):382-90; discussion 390-1. PubMed ID: 12803340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical relevance of HLA donor-specific antibodies detected by single antigen assay in kidney transplantation.
    Caro-Oleas JL; González-Escribano MF; González-Roncero FM; Acevedo-Calado MJ; Cabello-Chaves V; Gentil-Govantes MÁ; Núñez-Roldán A
    Nephrol Dial Transplant; 2012 Mar; 27(3):1231-8. PubMed ID: 21810767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical relevance of pre and post-transplant immune markers in kidney allograft recipients: anti-HLA and MICA antibodies and serum levels of sCD30 and sMICA.
    Solgi G; Furst D; Mytilineos J; Pourmand G; Amirzargar AA
    Transpl Immunol; 2012 Mar; 26(2-3):81-7. PubMed ID: 22182633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune responses to osteochondral allografts. Current knowledge and future directions.
    Friedlaender GE
    Clin Orthop Relat Res; 1983 Apr; (174):58-68. PubMed ID: 6339143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Anti-HLA antibodies after bone graft and their impact on kidney transplant programs].
    Mosconi G; Baraldi O; Fantinati C; Cappuccilli ML; Corsini S; Zanelli P; Bassi A; Buscaroli B; Feliciangeli G; Stefoni S
    G Ital Nefrol; 2009; 26 Suppl 45():S58-63. PubMed ID: 19382096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-HLA antibodies and kidney allograft outcomes in recipients with donor bone marrow cell infusion.
    Solgi G; Pourmand G; Mehrsai A; Taherimahmoudi M; Nicknam MH; Ebrahimi Rad MR; Seraji A; Asadpoor A; Ansaripor B; Nikbin B; Amirzargar A
    Iran J Immunol; 2010 Mar; 7(1):18-29. PubMed ID: 20371916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of pretransplant donor anti-recipient cytotoxic and helper T lymphocyte responses as correlates of acute graft-vs.-host disease and survival after unrelated marrow transplantation.
    Pei J; Martin PJ; Longton G; Masewicz S; Mickelson E; Petersdorf E; Anasetti C; Hansen J
    Biol Blood Marrow Transplant; 1997 Aug; 3(3):142-9. PubMed ID: 9310191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies against donor human leukocyte antigens and the outcome of cardiac allografts in adults and children.
    Stastny P; Lavingia B; Fixler DE; Yancy CW; Ring WS
    Transplantation; 2007 Sep; 84(6):738-45. PubMed ID: 17893607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA-typing analysis following allogeneic bone grafting for sinus lifting.
    Piaia M; Bub CB; Succi GM; Torres M; Costa TH; Pinheiro FC; Napimoga MH
    Cell Tissue Bank; 2017 Mar; 18(1):75-81. PubMed ID: 27783263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-HLA antibodies other than against HLA-A, -B, -DRB1 adversely affect engraftment and nonrelapse mortality in HLA-mismatched single cord blood transplantation: possible implications of unrecognized donor-specific antibodies.
    Yamamoto H; Uchida N; Matsuno N; Ota H; Kageyama K; Wada S; Kaji D; Nishida A; Ishiwata K; Takagi S; Tsuji M; Asano-Mori Y; Yamamoto G; Izutsu K; Masuoka K; Wake A; Yoneyama A; Makino S; Taniguchi S
    Biol Blood Marrow Transplant; 2014 Oct; 20(10):1634-40. PubMed ID: 24972251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Donor-specific HLA antibodies in paediatric cardiac transplant recipients are associated with poor graft survival.
    Irving C; Carter V; Parry G; Hasan A; Kirk R
    Pediatr Transplant; 2011 Mar; 15(2):193-7. PubMed ID: 21199210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term follow up for anti-HLA donor specific antibodies postrenal transplantation: high immunogenicity of HLA class II graft molecules.
    Ntokou IS; Iniotaki AG; Kontou EN; Darema MN; Apostolaki MD; Kostakis AG; Boletis JN
    Transpl Int; 2011 Nov; 24(11):1084-93. PubMed ID: 21848902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Donor-specific HLA antibodies after transplantation are associated with deterioration in cardiac function.
    Leech SH; Mather PJ; Eisen HJ; Pina IL; Margulies KB; Bove AA; Jeevanandam V
    Clin Transplant; 1996 Dec; 10(6 Pt 2):639-45. PubMed ID: 8996758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement-binding anti-HLA antibodies and kidney-allograft survival.
    Loupy A; Lefaucheur C; Vernerey D; Prugger C; Duong van Huyen JP; Mooney N; Suberbielle C; Frémeaux-Bacchi V; Méjean A; Desgrandchamps F; Anglicheau D; Nochy D; Charron D; Empana JP; Delahousse M; Legendre C; Glotz D; Hill GS; Zeevi A; Jouven X
    N Engl J Med; 2013 Sep; 369(13):1215-26. PubMed ID: 24066742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of HLA antibodies on graft survival in long-term renal recipients with functional grafts.
    Zeng Y; Liu Z; Liu Y; Fan Y; Guo Y; Qiu J
    Urol Int; 2014; 92(3):328-33. PubMed ID: 24480999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.